Goldman Sachs Adjusts Price Target on Boston Scientific to $116 From $119, Maintains Buy Rating

, MT Newswires -  6:29 AM ET 3/27/2025 default

  • Facebook.
  • Twitter.
  • LinkedIn.
  • Print

06:29 AM EDT, 03/27/2025 (MT Newswires) -- Boston Scientific ( BSX ) has an average rating of overweight and mean price target of $119.14, according to analysts polled by FactSet.

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

© 1999-2025 Midnight Trader, Inc. All rights reserved.

  • Facebook.
  • Twitter.
  • LinkedIn.
  • Print
close
Please enter a valid e-mail address
Please enter a valid e-mail address
Important legal information about the e-mail you will be sending. By using this service, you agree to input your real e-mail address and only send it to people you know. It is a violation of law in some jurisdictions to falsely identify yourself in an e-mail. All information you provide will be used by Fidelity solely for the purpose of sending the e-mail on your behalf.The subject line of the e-mail you send will be "Fidelity.com: "

Your e-mail has been sent.
close

Your e-mail has been sent.